FDA Approved: STROMECTOL — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved a supplemental application for Stromectol (ivermectin) filed by Merck Sharp & Dohme LLC, granting changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Nematode Infections
• Lymphatic Filariasis
• Onchocerciasis
• Scabies
• Strongyloidiasis

Drugs mentioned

• Stromectol (ivermectin)

Snippet

SUPPL AP for STROMECTOL (IVERMECTIN)